Holen Sie sich die Stockscreener-App
1.36
7.48%
-0.11
Handel nachbörslich:
1.35
-0.01
-0.74%
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - USA Today
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India
HeartBeam, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-03-12 - Seeking Alpha
Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com
BEAT: FDA-cleared at-home ECG, new partnerships, and improved cash position drive growth - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2025 Results - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences - USA Today
Panic Selling: Can HeartBeam Inc outperform in the next rally2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
HeartBeam announces first commercial customer as ClearCardio brings groundbreaking 12-lead ECG technology to high-growth preventive cardiology market - MSN
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai - Bitget
HeartBeam advances portable cardiac monitoring platform after FDA clearance - DOTmed
HeartBeam partners with Mount Sinai on AI-ECG development By Investing.com - Investing.com South Africa
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study - Stocktwits
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home - Stocktwits
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Stocktwits
HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - NewMediaWire
Heartbeam Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam partners with Mount Sinai on AI-ECG development - Investing.com Nigeria
HeartBeam and Mount Sinai Announce Strategic AI Collaboration - Medical Product Outsourcing
HeartBeam Enters Commercial Market, Boosts Cardiovascular Technology Horizons - timothysykes.com
HeartBeam to present at March investor conferences By Investing.com - Investing.com Canada
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch - Bluefield Daily Telegraph
Aug EndMonth: Is HeartBeam Inc. a cyclical or defensive stock2026 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Market Outlook: Can HeartBeam Inc maintain its current growth rate2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why HeartBeam Inc. stock attracts high net worth investorsOil Prices & Weekly Setup with ROI Potential - Naître et grandir
Support Test: What are HeartBeam Inc Equity Warrants recent SEC filings showingSwing Trade & Weekly Chart Analysis and Guides - baoquankhu1.vn
ClearCardio, HeartBeam Team Up to Bring 12-Lead ECG Technology to Preventive Cardiology Market - Diagnostic and Interventional Cardiology
HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - NewMediaWire
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - Digital Journal
HeartBeam Enrolls 1st Patients in ALIGN-ACS Heart Attack Study - Medical Product Outsourcing
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time - ChartMill
HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target - Digital Journal
BEAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform - Digital Journal
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Digital Journal
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - USA Today
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - USA Today
Risk On: Is SQNS stock a hidden gemMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn
HeartBeam (BEAT) Price Target Increased by 16.22% to 5.48 - Nasdaq
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - USA Today
Breakout Move: What are HeartBeam Inc Equity Warrants recent SEC filings showingEarnings Growth Report & Smart Money Movement Alerts - baoquankhu1.vn
Will HeartBeam Inc. benefit from rising consumer demand2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform - NewMediaWire
0.79%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):